1,689
Views
183
CrossRef citations to date
0
Altmetric
Original Article

Anti-Ro/SSA and La/SSB antibodies

&
Pages 55-63 | Received 20 Jul 2004, Accepted 08 Aug 2004, Published online: 07 Jul 2009

References

  • Jones B. Lacrimal and salivary precipitating antibodies in Sj6gren's syndrome. Lancet 1958;195:773–776.
  • Anderson JR, Gray KG, Beck JS. Precipitating autoanti-bodies in Sjögren's disease. Lancet 1961;2:456–460.
  • Clark G, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117–122.
  • Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sj6gren's syndrome. J Chin Investig 1975;22:1067–1073.
  • Alspaugh MA, Maddison PJ. Resolution of the identity of certain antigen—antibody systems in systemic lupus ery-thematosus and Sjögren's syndrome. Arthritis Rheum 1979;22:796–798.
  • Azikuki M, Powers JR, Holman HR. A soluble acid protein of the cell nucleus which reacts with serum from patients with systemic lupus erythematosus and Sjögren's syndrome. J Chin Investig 1977;59:264–271.
  • Lerner MR, Boyle JA, Hardin JA, Steitz JA. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 1981;211:400–402.
  • Hendrick JP, Wolin SL, Rinke J, Lerner MR, Steitz JA. Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol 1981;1:1138–1149.
  • Wolin SL, Steitz JA. The Ro small cytoplasmic ribonucleo-proteins: identification of the antigenic protein and its binding on the Ro RNAs. Proc Natl Acad Sci USA 1984;81:1996–2000.
  • Ben-Chetrit E, Gandy BJ, Tan EM, Sullivan KF. Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Chin Investig 1989;83: 1284–1292.
  • McCauliffe DP, Zappi E, Lieu TS, Michalak M, Sontheimer RD, Capra DJ. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule". J Chin Investig 1990;86:332–335.
  • Frank MB, Itoh K, Fujisaku A, Pontarotti P, Mattei MG, Neas BR. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. Am J Hum Genet 1993;52:183–191.
  • Chan EKL,, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Chin Investig 1991;87:68–76.
  • Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent I: anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992;14:57–65.
  • Boire G, Craft J. Biochemical and immunological hetero-geneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle. J Clin Investig 1989;84:270–279.
  • Boire G, Lopez-Longo FJ, Lapointe S, Menard HA. Sera from patients with autoimmune disease recognize confor-mational determinants on the 60-kd Ro/SS-A protein. Arthritis Rheum 1991;34:722–730.
  • Itoh Y, Itoh K, Frank MB, Reichlin M. Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: Antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity 1992;14: 89–95.
  • Boire G, Gendron M, Monast N, Bastin B, Menard HA. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Chin Exp Immunol 1995;100: 489–498.
  • Kurien BT, Chambers TL, Thomas PY, Frank MB, Scofield RH. Autoantibody to the leucine zipper region of 52 kDa Ro/SSA binds native 60 kDa Ro/SSA: Identification of a tertiary epitope with components from 60 kDa Ro/SSA and 52 kDa Ro/SSA. Scand J Immunol 2001;53: 268–276.
  • Rosa MD, Gottlieb E, Lerner MR, Steitz JA. Striking similarities are exhibited by two small Ebstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1981;1:785–796.
  • Van Venroij W, Slobbe R, Pruijn G. Structure and function of La and Ro RNPs. Mol Biol Rep 1993;18:113–121.
  • Maddison PJ, Provost TT, Reichlin M. Serologic findings in patients with "ANA-negative" SLE. Medicine (Balt) 1981;60:87–94.
  • Provost TT, Arnett FC, Reichlin M. C2 deficiency, lupus erythematosus, and anti-cytoplasmic Ro(SS-A) antibodies. Arthritis Rheum 1983;26: 1279–1282.
  • Tappainer G, Hintner H, Scholz S, Albert E, Lihert J, Wolff K. Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad Dermatol 1982;7:66–79.
  • Provost TT, Talal N, Harley JB, Reichlin M, Alexander EL. The relationship between anti-Ro (SS-A) antibody positive Sjögren's syndrome and anti-Ro(SS-A) antibody positive lupus erythematosus. Arch Dermatol 1998;124:63–71.
  • McCauliffe DP. Cutaneous diseases in adults associated with anti-Ro/SS-A autoantibody production. Lupus 1997;6:158–166.
  • Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, Lockshin MD. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Arthritis Rheum 1993;36:1263–1273.
  • Meyer O, Hauptmann G, Tappainer G, Ochs HD, Mascart-Lemone E Genetic deficiency of C4, C2 or C 1 q and lupus syndromes. Association with anti-Ro(SSA) antibodies. Chin Exp Immunol 1985;62:678.
  • Skopouli FN, Andonopoulos AP, Moutsopoulos HM. Clinical implication of the presence of anti-Ro(SSA) antibodies in patients with rheumatoid arthritis. J Auto-immun 1988;3:381–388.
  • Bernstein RM, Bunn CC, Hughes GRV, Francoeur AM, Mathews MP. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984;2:105–120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.